Business
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
ADOPT Study Findings Highlight Nanox.AI’s Role in Enhancing Fracture Detection and Healthcare Cost Savings PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd will present new data from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study at four major upcoming medical conferen
About this update from Nano-x Imaging Ltd
[{"type":"image","alt":"Nano-X Imaging LTD.","displaySize":"","headline":null,"caption":"Nano-X Imaging LTD.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/13ZFHOV0PmhW0sUP.nWsmQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a","width":250,"height":64}},"lazy":false},{"type":"text","content":"ADOPT Study Findings Highlight Nanox.AI’s Role in Enhancing Fracture Detection and Healthcare Cost Savings","length":116,"tagName":"p"},{"type":"text","content":"PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd will present new data from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study at four major upcoming medical conferences spanning March through June 2025.","length":450,"tagName":"p"},{"type":"text","content":"The ADOPT study concluded in February 2025 and evaluated HealthVCF at four National Health Services (NHS) trusts: Cambridge, Bradford, Cardiff and Southampton – coordinated by the long-standing clinical users at Oxford. In earlier findings from the ADOPT study, HealthVCF analyzed 37,220 routine medical CT scans and identified over 3,450 new patients with vertebral compression fractures, up to six times more than the national average at NHS hospitals in the UK. These patients were asymptomatic, and the early data underscores the importance of addressing the critical gap in detection of patients with vertebral fractures.","length":626,"tagName":"p"},{"type":"text","content":"Kassim Javaid, Professor of Osteoporosis and Adult Rare Bone Diseases and lead investigator of the ADOPT study, will present expanded data from the study showcasing the clinical utility of the AI bone solution in assessing bone health and identifying key indicators of osteoporosis, along with the benefits of various approaches to its implementation and the effect it can have on the rate of patient detection. The presented data will also show the economic benefit that such AI to...